ASX - By Stock
|
MSB |
Re:
Valuing Mesoblast based on revenue
|
|
Mason14
|
223 |
102K |
2 |
28/12/24 |
28/12/24 |
ASX - By Stock
|
223
|
102K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Valuing Mesoblast based on revenue
|
|
Mason14
|
223 |
102K |
6 |
27/12/24 |
27/12/24 |
ASX - By Stock
|
223
|
102K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Valuing Mesoblast based on revenue
|
|
Mason14
|
223 |
102K |
33 |
25/12/24 |
25/12/24 |
ASX - By Stock
|
223
|
102K
|
33
|
|
Charts
|
RAC |
Re:
RAC Charts
|
|
Mason14
|
1.8K |
1.0M |
22 |
25/12/24 |
25/12/24 |
Charts
|
1.8K
|
1.0M
|
22
|
|
ASX - By Stock
|
MSB |
Re:
Valuing Mesoblast based on revenue
|
|
Mason14
|
223 |
102K |
21 |
23/12/24 |
23/12/24 |
ASX - By Stock
|
223
|
102K
|
21
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Issuance of Convertible Notes & Warrants for up to $46m
|
|
Mason14
|
99 |
39K |
16 |
23/12/24 |
23/12/24 |
ASX - By Stock
|
99
|
39K
|
16
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Issuance of Convertible Notes & Warrants for up to $46m
|
|
Mason14
|
99 |
39K |
21 |
23/12/24 |
23/12/24 |
ASX - By Stock
|
99
|
39K
|
21
|
|
ASX - By Stock
|
IMU |
Re:
EGM for Cap raising announced via email
|
|
Mason14
|
22 |
9.2K |
20 |
23/12/24 |
23/12/24 |
ASX - By Stock
|
22
|
9.2K
|
20
|
|
ASX - By Stock
|
MSB |
Re:
Valuing Mesoblast based on revenue
|
|
Mason14
|
223 |
102K |
18 |
23/12/24 |
23/12/24 |
ASX - By Stock
|
223
|
102K
|
18
|
|
ASX - By Stock
|
TYP |
Re:
Ann: Positive interim results in Phase 2a TRP-8802 IBS trial
|
|
Mason14
|
10 |
3.4K |
19 |
21/12/24 |
21/12/24 |
ASX - By Stock
|
10
|
3.4K
|
19
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Submits Human Ethics for RC220 Phase 1 Trial
|
|
Mason14
|
340 |
97K |
12 |
21/12/24 |
21/12/24 |
ASX - By Stock
|
340
|
97K
|
12
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Approves Mesoblast Ryoncil
|
|
Mason14
|
559 |
208K |
4 |
21/12/24 |
21/12/24 |
ASX - By Stock
|
559
|
208K
|
4
|
|
ASX - By Stock
|
RAC |
Re:
Cardioprotection thread
|
|
Mason14
|
988 |
310K |
17 |
21/12/24 |
21/12/24 |
ASX - By Stock
|
988
|
310K
|
17
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
Mason14
|
28K |
14M |
22 |
20/12/24 |
20/12/24 |
ASX - By Stock
|
28K
|
14M
|
22
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Strengthens Board
|
|
Mason14
|
61 |
15K |
21 |
20/12/24 |
20/12/24 |
ASX - By Stock
|
61
|
15K
|
21
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Approves Mesoblast Ryoncil
|
|
Mason14
|
559 |
208K |
7 |
19/12/24 |
19/12/24 |
ASX - By Stock
|
559
|
208K
|
7
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Strengthens Board
|
|
Mason14
|
61 |
15K |
16 |
18/12/24 |
18/12/24 |
ASX - By Stock
|
61
|
15K
|
16
|
|
ASX - By Stock
|
RAC |
Re:
Cardioprotection thread
|
|
Mason14
|
988 |
310K |
39 |
18/12/24 |
18/12/24 |
ASX - By Stock
|
988
|
310K
|
39
|
|
ASX - By Stock
|
RAC |
Re:
Cardioprotection thread
|
|
Mason14
|
988 |
310K |
27 |
17/12/24 |
17/12/24 |
ASX - By Stock
|
988
|
310K
|
27
|
|
ASX - By Stock
|
TYP |
Re:
Ann: Phase 1b extension results meet study objectives
|
|
Mason14
|
6 |
2.0K |
17 |
17/12/24 |
17/12/24 |
ASX - By Stock
|
6
|
2.0K
|
17
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
Mason14
|
23K |
8.3M |
69 |
16/12/24 |
16/12/24 |
ASX - By Stock
|
23K
|
8.3M
|
69
|
|
ASX - By Stock
|
RAC |
Re:
Is RAC undervalued? the rNPV says...
|
|
Mason14
|
35 |
13K |
55 |
16/12/24 |
16/12/24 |
ASX - By Stock
|
35
|
13K
|
55
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
Mason14
|
28K |
14M |
12 |
15/12/24 |
15/12/24 |
ASX - By Stock
|
28K
|
14M
|
12
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
Mason14
|
28K |
14M |
0 |
14/12/24 |
14/12/24 |
ASX - By Stock
|
28K
|
14M
|
0
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
Mason14
|
28K |
14M |
15 |
14/12/24 |
14/12/24 |
ASX - By Stock
|
28K
|
14M
|
15
|
|
ASX - By Stock
|
TYP |
Re:
Ann: Completion of Phase 1b study of TRP-8803 in obese subjects
|
|
Mason14
|
9 |
4.2K |
5 |
13/12/24 |
13/12/24 |
ASX - By Stock
|
9
|
4.2K
|
5
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Submits Human Ethics for RC220 Phase 1 Trial
|
|
Mason14
|
340 |
97K |
32 |
13/12/24 |
13/12/24 |
ASX - By Stock
|
340
|
97K
|
32
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Submits Human Ethics for RC220 Phase 1 Trial
|
|
Mason14
|
340 |
97K |
2 |
13/12/24 |
13/12/24 |
ASX - By Stock
|
340
|
97K
|
2
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Submits Human Ethics for RC220 Phase 1 Trial
|
|
Mason14
|
340 |
97K |
5 |
13/12/24 |
13/12/24 |
ASX - By Stock
|
340
|
97K
|
5
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Submits Human Ethics for RC220 Phase 1 Trial
|
|
Mason14
|
340 |
97K |
1 |
13/12/24 |
13/12/24 |
ASX - By Stock
|
340
|
97K
|
1
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Submits Human Ethics for RC220 Phase 1 Trial
|
|
Mason14
|
340 |
97K |
38 |
13/12/24 |
13/12/24 |
ASX - By Stock
|
340
|
97K
|
38
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Submits Human Ethics for RC220 Phase 1 Trial
|
|
Mason14
|
340 |
97K |
33 |
12/12/24 |
12/12/24 |
ASX - By Stock
|
340
|
97K
|
33
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Submits Human Ethics for RC220 Phase 1 Trial
|
|
Mason14
|
340 |
97K |
45 |
12/12/24 |
12/12/24 |
ASX - By Stock
|
340
|
97K
|
45
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Submits Human Ethics for RC220 Phase 1 Trial
|
|
Mason14
|
340 |
97K |
40 |
11/12/24 |
11/12/24 |
ASX - By Stock
|
340
|
97K
|
40
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Submits Human Ethics for RC220 Phase 1 Trial
|
|
Mason14
|
340 |
97K |
42 |
11/12/24 |
11/12/24 |
ASX - By Stock
|
340
|
97K
|
42
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Submits Human Ethics for RC220 Phase 1 Trial
|
|
Mason14
|
340 |
97K |
12 |
10/12/24 |
10/12/24 |
ASX - By Stock
|
340
|
97K
|
12
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Submits Human Ethics for RC220 Phase 1 Trial
|
|
Mason14
|
340 |
97K |
3 |
10/12/24 |
10/12/24 |
ASX - By Stock
|
340
|
97K
|
3
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Submits Human Ethics for RC220 Phase 1 Trial
|
|
Mason14
|
340 |
97K |
4 |
10/12/24 |
10/12/24 |
ASX - By Stock
|
340
|
97K
|
4
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Submits Human Ethics for RC220 Phase 1 Trial
|
|
Mason14
|
340 |
97K |
17 |
10/12/24 |
10/12/24 |
ASX - By Stock
|
340
|
97K
|
17
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Mason14
|
12K |
4.3M |
8 |
09/12/24 |
09/12/24 |
General
|
12K
|
4.3M
|
8
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Mason14
|
12K |
4.3M |
55 |
09/12/24 |
09/12/24 |
General
|
12K
|
4.3M
|
55
|
|
ASX - By Stock
|
RAC |
Re:
RAC "eye opener" Series
|
|
Mason14
|
102 |
27K |
11 |
09/12/24 |
09/12/24 |
ASX - By Stock
|
102
|
27K
|
11
|
|
ASX - By Stock
|
RAC |
Re:
RAC "eye opener" Series
|
|
Mason14
|
102 |
27K |
33 |
09/12/24 |
09/12/24 |
ASX - By Stock
|
102
|
27K
|
33
|
|
ASX - By Stock
|
RAC |
Re:
RAC "eye opener" Series
|
|
Mason14
|
102 |
27K |
55 |
09/12/24 |
09/12/24 |
ASX - By Stock
|
102
|
27K
|
55
|
|
ASX - By Stock
|
RAC |
Re:
RAC "eye opener" Series
|
|
Mason14
|
102 |
27K |
15 |
08/12/24 |
08/12/24 |
ASX - By Stock
|
102
|
27K
|
15
|
|
ASX - By Stock
|
RAC |
Re:
RAC "eye opener" Series
|
|
Mason14
|
102 |
27K |
21 |
08/12/24 |
08/12/24 |
ASX - By Stock
|
102
|
27K
|
21
|
|
ASX - By Stock
|
RAC |
Re:
RAC "eye opener" Series
|
|
Mason14
|
102 |
27K |
24 |
08/12/24 |
08/12/24 |
ASX - By Stock
|
102
|
27K
|
24
|
|
ASX - By Stock
|
RAC |
Re:
RAC "eye opener" Series
|
|
Mason14
|
102 |
27K |
24 |
08/12/24 |
08/12/24 |
ASX - By Stock
|
102
|
27K
|
24
|
|
ASX - By Stock
|
RAC |
Re:
RAC "eye opener" Series
|
|
Mason14
|
102 |
27K |
12 |
08/12/24 |
08/12/24 |
ASX - By Stock
|
102
|
27K
|
12
|
|
ASX - By Stock
|
RAC |
Re:
RAC "eye opener" Series
|
|
Mason14
|
102 |
27K |
30 |
08/12/24 |
08/12/24 |
ASX - By Stock
|
102
|
27K
|
30
|
|